Heron Therapeutics, Inc.
HRTX
$0.84
-$0.03-3.04%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -21.34% | -21.73% | -39.67% | -29.14% | -26.27% |
| Total Receivables | 13.57% | 20.90% | 8.44% | 20.54% | 31.17% |
| Inventory | 74.47% | 52.39% | 70.22% | 34.04% | 26.24% |
| Prepaid Expenses | -48.55% | 101.99% | 139.95% | 302.40% | 189.15% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 13.90% | 17.53% | 10.33% | 14.49% | 10.72% |
|
|
|||||
| Total Current Assets | 13.90% | 17.53% | 10.33% | 14.49% | 10.72% |
| Net Property, Plant & Equipment | -29.73% | -27.62% | -24.72% | -31.00% | -31.07% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -16.58% | -12.30% | -12.22% | -20.31% | -20.24% |
| Total Assets | 9.75% | 12.76% | 6.40% | 8.20% | 4.78% |
|
|
|||||
| Total Accounts Payable | -23.19% | 17.95% | 17.71% | 1,373.48% | 261.39% |
| Total Accrued Expenses | 13.55% | 94.55% | 119.34% | 113.17% | 4.55% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -75.99% | 5,433.59% | -27.00% | -1.24% |
| Total Finance Division Other Current Liabilities | -- | -87.12% | -88.43% | -89.24% | -- |
| Total Other Current Liabilities | -- | -87.12% | -88.43% | -89.24% | -- |
| Total Current Liabilities | 5.07% | 4.87% | 221.98% | 17.48% | 14.77% |
|
|
|||||
| Total Current Liabilities | 5.07% | 4.87% | 221.98% | 17.48% | 14.77% |
| Long-Term Debt | -19.51% | -19.95% | -- | 0.56% | 0.56% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 681.79% | 1,847.72% | 209.96% | 182.99% | 155.19% |
| Total Liabilities | -9.47% | -10.24% | 1.28% | 4.99% | 4.02% |
|
|
|||||
| Common Stock & APIC | 3.56% | 3.22% | 0.62% | 0.70% | 0.74% |
| Retained Earnings | -1.05% | -0.71% | -0.05% | -0.41% | -0.71% |
| Treasury Stock & Other | -69.23% | -- | 87.50% | 116.67% | 0.00% |
| Total Common Equity | 139.47% | 117.56% | 28.15% | 15.73% | 0.95% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 139.47% | 117.56% | 28.15% | 15.73% | 0.95% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 142.59% | 137.21% | 28.15% | 15.73% | 0.95% |
|
|
|||||